Multiple studies have reported tumor suppressor roles for TNFAIP3 in inhibiting NF-κB in chronic myeloid leukemia [38], suppressing EMT, cell migration and invasion in nasopharyngeal carcinoma [39], and inhibiting liver inflammation, hepatocellular carcinoma proliferation, and metastasis through inhibition of Twist1 expression and TNFα-induced cell motility [40]. The gene discussed is TNFAIP3; the disease is neoplasm.